Last update 15 May 2025

EP4186891

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PPARα x PPARδ
Action
agonists
Mechanism
PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARδ agonists(Peroxisome proliferator-activated receptor delta agonists)
Therapeutic Areas
NeoplasmsImmune System DiseasesNervous System Diseases+ [7]
Active Indication
AsthmaCardiovascular DiseasesDigestive System Disorders+ [6]
Inactive Indication-
Originator Organization
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
Active Organization
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with EP4186891
Login to view more data
100 Translational Medicine associated with EP4186891
Login to view more data
100 Patents (Medical) associated with EP4186891
Login to view more data
100 Deals associated with EP4186891
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Cardiovascular DiseasesDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Digestive System DisordersDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Endocrinology and Metabolic DiseaseDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
HypoproteinemiaDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
InflammationDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
NeoplasmsDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Nervous System DiseasesDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Skin and Musculoskeletal DiseasesDiscovery-
CHENGDU FANXI BIOPHARMA CO., LTD.CHENGDU FANXI BIOPHARMA CO., LTD.
31 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free